San Diego’s Approach to MAT for Opioid Care
Introduction
Opioid use disorder (OUD) remains a significant public health concern in San Diego, California, including communities such as Downtown San Diego, Chula Vista, La Jolla, El Cajon, Oceanside, and surrounding areas. In recent years, the increasing presence of illicitly manufactured fentanyl has substantially raised the risk of overdose across San Diego County.
Moreover, national data from the Centers for Disease Control and Prevention indicate that synthetic opioids, primarily fentanyl, are now involved in the majority of opioid-related deaths in the United States. As these trends continue to evolve, they underscore the growing impact of illicit fentanyl on overdose mortality nationwide. Importantly, local trends in San Diego County closely mirror these national patterns, underscoring the widespread impact of fentanyl across both urban and suburban communities.
Given this evolving landscape, timely access to evidence-based treatment has become increasingly critical. In particular, Medication-Assisted Treatment (MAT) is recognized by the Substance Abuse and Mental Health Services Administration as the standard of care for opioid use disorder. Accordingly, San Diego’s approach integrates clinical programs, behavioral health services, coordinated public health initiatives, and expanded telehealth access. Together, these efforts aim to improve treatment accessibility, enhance continuity of care, and ultimately reduce overdose risk throughout the region.
Overview of Medication-Assisted Treatment (MAT) in San Diego
Defining MAT for Opioid Use Disorder
Medication-Assisted Treatment refers to the use of FDA-approved medications, combined with behavioral health support, to treat opioid use disorder.
According to SAMHSA, approved medications include:
- Methadone
- Buprenorphine
- Naltrexone
Accordingly, these medications work by stabilizing brain opioid receptors, which in turn helps reduce cravings and prevent withdrawal symptoms. As a result, individuals are better able to maintain physiological stability while engaging in ongoing treatment. When clinicians properly prescribe and closely monitor medication-assisted treatment, it not only decreases illicit opioid use but also significantly lowers the risk of fatal overdose. Consequently, MAT remains a central component of evidence-based care for opioid use disorder.
MAT is not a substitution of one addiction for another. It is a structured medical treatment for a chronic brain-based disorder, delivered under physician supervision.
Importance of MAT in San Diego County
San Diego County has experienced increased fentanyl involvement in overdose deaths. Because fentanyl is highly potent and frequently mixed into illicit drug supplies, individuals with untreated opioid use disorder face elevated risk.
MAT plays a critical role by:
- Reducing illicit opioid consumption
- Lowering fatal overdose risk
- Improving retention in treatment
- Supporting long-term recovery stability
Evidence from national public health research consistently demonstrates that individuals receiving MAT have significantly lower mortality rates compared to those who do not receive medication-based treatment.
How MAT Programs Are Structured in San Diego
San Diego County offers multiple treatment delivery models to improve access across diverse communities.
MAT Clinic Models in San Diego
Available models include:
- Opioid Treatment Programs (OTPs) dispensing methadone under federal regulation
- Office-based buprenorphine providers
- Federally Qualified Health Centers (FQHCs)
- Integrated behavioral health clinics
- Telehealth-based MAT providers
Depending on clinical stability, some patients receive daily supervised dosing, while others may qualify for take-home medications under established treatment guidelines.
Integration with Behavioral Health Services
Comprehensive MAT programs in San Diego often include:
- Individual counseling
- Group therapy
- Peer recovery support
- Case management services
- Treatment for co-occurring mental health conditions
Co-occurring psychiatric disorders, including depression and anxiety, are common in patients with opioid use disorder. Integrated care improves long-term outcomes and reduces relapse risk.
Medications Used in San Diego MAT Programs
Methadone
Methadone is a full opioid agonist dispensed through licensed opioid treatment programs. It reduces withdrawal symptoms and opioid cravings under structured medical supervision.
Buprenorphine (Suboxone)
Buprenorphine is a partial opioid agonist commonly prescribed in outpatient and telehealth settings. It has a ceiling effect, which lowers the risk of respiratory depression compared to full agonists.
Buprenorphine/naloxone (Suboxone) is frequently used in San Diego to:
- Stabilize withdrawal symptoms
- Reduce cravings
- Decrease relapse risk
Naltrexone
Naltrexone is an opioid antagonist that blocks opioid receptors. It is typically initiated after detoxification and prevents opioid effects if relapse occurs.
All three medications are supported by federal treatment guidelines and extensive clinical research.
Choosing the Appropriate Medication
Medication selection is individualized and based on:
- Severity of opioid dependence
- History of prior treatment
- Co-occurring medical conditions
- Patient preference
- Accessibility and treatment setting
A licensed physician conducts a comprehensive evaluation to determine the safest and most effective treatment plan.
Role of Community Health Clinics in San Diego
Community health centers and nonprofit clinics play an essential role in expanding access to MAT across San Diego County.
Many clinics:
- Accept Medi-Cal
- Offer sliding scale payment options
- Provide multilingual services
- Coordinate with housing and employment programs
San Diego County also supports harm reduction strategies, including naloxone distribution and overdose education programs.
Coordinated care between medical providers, behavioral health services, and social support systems improves treatment retention and reduces relapse risk.
Initiating MAT for Opioid Addiction in San Diego
Steps to Begin Treatment
Starting MAT typically involves several coordinated steps designed to ensure both safety and long-term success. To begin with, individuals schedule an evaluation with a licensed provider, which serves as the foundation for the treatment process. During this initial step, clinicians assess medical history, substance use patterns, and overall health in order to determine the most appropriate course of care. During this initial visit, clinicians complete a comprehensive medical and substance use history in order to understand the full clinical picture. Based on this assessment, the provider then develops an individualized treatment plan tailored to the patient’s needs. When clinically appropriate, medication is initiated under medical supervision, followed by ongoing follow-up appointments and structured monitoring to support stabilization and adherence.
In addition, telehealth services now allow many San Diego residents to complete both initial evaluations and follow-up visits remotely. As a result, access to care improves for individuals facing transportation challenges, work schedule constraints, childcare responsibilities, or other logistical barriers that might otherwise delay treatment.
Professional Consultation Resources
San Diego residents may contact:
- San Diego County Health and Human Services Agency
- SAMHSA National Helpline (1-800-662-HELP)
These services provide confidential treatment referrals and crisis support.
Physician-Led Suboxone Treatment in San Diego, California
DevotedDOC provides physician-led telehealth treatment for opioid use disorder in San Diego County and throughout California.
Clinical Evaluation and Oversight
Patients receive a comprehensive assessment conducted by a licensed California physician. Diagnosis follows DSM-5 criteria for opioid use disorder.
When clinically appropriate, buprenorphine/naloxone (Suboxone) may be prescribed as part of an evidence-based treatment plan.
Care includes:
- Structured medication induction
- Ongoing dose monitoring
- Periodic clinical reassessment
- Urine drug screening when clinically indicated
- Pharmacy coordination
Telehealth Access and Confidentiality
All visits are conducted through secure, HIPAA-compliant telemedicine systems. Telehealth improves accessibility for residents in:
- Downtown San Diego
- La Jolla
- Chula Vista
- Pacific Beach
- Surrounding San Diego communities
Administrative Office:
11620 Wilshire Blvd, Suite 600
Los Angeles, CA 90025
Phone: (213) 786-3063
Patients must schedule appointments in advance to ensure appropriate clinical preparation and continuity of care. In addition, licensed providers conduct all San Diego visits through telehealth in full compliance with California and federal regulations, thereby maintaining regulatory integrity and patient safety.
Through this model, DevotedDOC consistently emphasizes:
- Physician oversight at every stage of treatment
- Evidence-based prescribing practices
- Structured follow-up and clinical monitoring
- Confidential, HIPAA-compliant care
Ultimately, the primary objective remains long-term stabilization and meaningful overdose risk reduction rather than short-term or episodic prescribing.
Conclusion
In response to the growing opioid crisis, San Diego has proactively developed a comprehensive and coordinated approach to medication-assisted treatment. Specifically, the region integrates public health infrastructure, community clinics, physician-led care, and expanded telehealth access in order to improve continuity of care. By bringing these systems together, San Diego aims to strengthen treatment accessibility, enhance clinical oversight, and more effectively address the evolving challenges of opioid use disorder. As the fentanyl era continues to reshape overdose risk across the region, this coordinated model becomes even more critical. Consequently, timely access to structured medical treatment plays a central role in reducing overdose mortality and strengthening long-term recovery outcomes.
Accordingly, national public health authorities recognize Medication-Assisted Treatment as the standard of care for opioid use disorder. National public health authorities strongly support it, and decades of clinical research continue to reinforce its effectiveness. Moreover, extensive evidence demonstrates that integrating medication with behavioral and psychosocial support significantly improves retention in care and reduces the risk of fatal overdose.
If you or someone in San Diego is living with opioid use disorder, early evaluation by a licensed physician can significantly reduce risk and support long-term recovery.
👉 Book a telehealth visit this week
👉 Call (213) 786-3063 for confidential assistance
👉 Learn more about physician-led Suboxone treatment in San Diego
References
- Centers for Disease Control and Prevention. Provisional Drug Overdose Death Counts and Synthetic Opioid Trends in the United States.
- San Diego County Health and Human Services Agency. Substance Use Disorder Services and Overdose Surveillance Reports.
- Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder (Treatment Improvement Protocol – TIP 63).
- Food and Drug Administration. FDA-Approved Medications for the Treatment of Opioid Use Disorder.
- National Institute on Drug Abuse. Medications to Treat Opioid Use Disorder Research Reports.
- National Institutes of Health. Evidence on Medication-Assisted Treatment and Overdose Mortality Reduction.
- California Department of Public Health. California Opioid Overdose Surveillance Dashboard.
- Drug Enforcement Administration. Opioid Treatment Program Regulations and Buprenorphine Prescribing Guidance.
- Centers for Medicare & Medicaid Services. Guidance on Medication-Assisted Treatment and Coverage Policies.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) – Criteria for Opioid Use Disorder.
